Clinical trial

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

NCT07644598

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE2

Study timeline

Study start (estimated)2026-09-01Date precision: month

Registry last updated2026-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Localized Prostate Carcinomaunresolved

Interventions

Microboost SBRTRADIATION

Whole gland de-escalation 30 GyRADIATION

Whole gland de-escalation 35 GyRADIATION

Sponsors & collaborators

Georgetown Universitylead sponsor

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07644598 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.